Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on February 3, 2014. The filing serves as a Regulation FD disclosure regarding the distribution of a letter and a newsletter to stockholders. The newsletter provides an abbreviated year-in-review for 2013 concerning the Company's ClearPoint system.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document references a newsletter containing a year-in-review but does not include the financial data within the text of the 8-K itself.
Material Changes
No material financial changes or comparative period data are disclosed in this filing. The report focuses solely on the dissemination of the 2013 ClearPoint system newsletter.
Guidance, Outlook, and Risks
The Company explicitly states that the information furnished is summary in nature and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Management undertakes no duty or obligation to publicly update or revise the information contained in the newsletter, though they may do so at their discretion. The filing notes that active hyperlinks in the newsletter are not accessible in the exhibit but are available on the Company's website.
Investor Verification Checklist
- Verify the specific 2013 financial performance and ClearPoint system metrics by accessing the full newsletter at the Company's website (www.mriinterventions.com/clearpoint/clearpoint-newsletter).
- Confirm that the summary information in the newsletter is consistent with the Company's formal SEC filings (e.g., 10-K, 10-Q).
- Note that the information in this 8-K is not incorporated by reference into other filings unless expressly stated.